Tech Talks with Holly Scott

Guest: David Constantine

27 min · 23. elo 2024
jakson Guest: David Constantine kansikuva

Kuvaus

Neuromodulation is a rapidly growing market, with significant investments in pelvic health, including Boston Scientific's $3.4 billion acquisition of Axonics and funding for Amber Therapeutics, Neuspera Medical, and Avation Medical. David Constantine, Co-Founder and CEO of Juniper Biomedical, has leveraged his career experiences to drive their mission of revolutionizing pelvic health through precision neuromodulation. His passion for impactful work highlights the importance of finding meaningful career paths that motivate and sustain us through challenges. This conversation with David underscored the timely relevance of their innovative approach in transforming patient outcomes.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Tech Talks with Holly Scott-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

22 jaksot